We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current SLNO market cap is 2.17B. The company's latest EPS is USD -0.9042 and P/E is -55.62.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -10.38M | -13.91M | -23.48M | -23.87M | -81.21M |
| Net Income | -10.86M | -11.3M | -21.4M | -20.85M | -77.62M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -23.49M | -36.29M | -32.26M | -25.11M | -41.38M |
| Net Income | -30.77M | -24.64M | -30.91M | -24.07M | -38.99M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 63.55M | 180.69M | 168.84M | 304.13M | 296.71M |
| Total Liabilities | 40.33M | 23.18M | 25.45M | 23.37M | 32.01M |
| Total Equity | 23.22M | 157.51M | 143.39M | 280.76M | 264.7M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 38.17M | 64.98M | 35.55M | 26.5M | 180.69M |
| Total Liabilities | 23.23M | 19.44M | 17.76M | 16.15M | 23.18M |
| Total Equity | 14.95M | 45.55M | 17.79M | 10.35M | 157.51M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -18.63M | -24.94M | -12.53M | -30.18M | -45.11M |
| Investing | N/A | N/A | -115.24M | -236.17M | -232.13M |
| Financing | 56.46M | 180.02M | 938k | 153.69M | 155.96M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -17.38M | -25.22M | -27.77M | -20.78M | -24.94M |
| Investing | 528k | -7k | -22k | -13k | N/A |
| Financing | 14.48M | 53.72M | -128k | 14.09M | 180.02M |
| Market Cap | 2.17B |
| Price to Earnings Ratio | -55.62 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 12.78 |
| Price to Book Ratio | 13.77 |
| Dividend Yield | - |
| Shares Outstanding | 43.12M |
| Average Volume (1 week) | 354.3k |
| Average Volume (1 Month) | 389.54k |
| 52 Week Change | 3.80% |
| 52 Week High | 60.92 |
| 52 Week Low | 36.61 |
| Spread (Intraday) | 4.47 (8.56%) |
| Company Name | Soleno Therapeutics Inc |
| Address |
corporation trust center 1209 orange st wilmington, delaware 19801 |
| Website | https://www.capnia.com |
| Industry | electromedical apparatus (3845) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
